Obtain free CME credit online
FDA warns of drug compounding amid shortages of drugs containing semaglutide
June 7th 2023Semaglutide (Wegovy; Novo Nordisk) for obesity in adolescents, along with 2 other approved products containing semaglutide, are currently on the FDA’s drug shortages list, prompting the agency to warn patients and providers about drug compounding.
2 Clarke Drive
Cranbury, NJ 08512